These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32058261)

  • 21. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
    Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
    Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited efficacy of the ketogenic diet in the treatment of highly refractory epileptic spasms.
    Hussain SA; Shin JH; Shih EJ; Murata KK; Sewak S; Kezele ME; Sankar R; Matsumoto JH
    Seizure; 2016 Feb; 35():59-64. PubMed ID: 26803052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
    Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
    Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epileptic spasms without hypsarrhythmia in infancy and childhood: tonic spasms as a seizure type.
    Marchi LR; Seraphim EA; Corso JT; Naves PV; Carvalho KC; Ramirez MD; Ferrari-Marinho T; Guaranha MS; Yacubian EM
    Epileptic Disord; 2015 Jun; 17(2):188-93. PubMed ID: 25895540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: A multicenter phase-2 study.
    Hussain SA; Dlugos DJ; Cilio MR; Parikh N; Oh A; Sankar R
    Epilepsy Behav; 2020 Jan; 102():106826. PubMed ID: 31816477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of infantile spasms.
    Hancock E; Osborne J; Milner P
    Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of epileptic spasms: A study of 21 children.
    Caraballo R; Semprino M; Fasulo L; Reyes G; Chacón S; Gallo A; Buompadre C
    Epilepsy Behav; 2022 Jan; 126():108451. PubMed ID: 34864379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical treatment of patients with infantile spasms.
    Mikati MA; Lepejian GA; Holmes GL
    Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strength and stability of EEG functional connectivity predict treatment response in infants with epileptic spasms.
    Shrey DW; Kim McManus O; Rajaraman R; Ombao H; Hussain SA; Lopour BA
    Clin Neurophysiol; 2018 Oct; 129(10):2137-2148. PubMed ID: 30114662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L
    Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy.
    Jackson MC; Jafarpour S; Klehm J; Thome-Souza S; Coughlin F; Kapur K; Loddenkemper T
    Epilepsia; 2017 Sep; 58(9):1575-1585. PubMed ID: 28691157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
    Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
    Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and electroclinical evolution in 22 cases with epileptic spasms without hypsarrhythmia.
    Koichihara R; Hamano SI; Daida A; Nonoyama H; Ikemoto S; Hirata Y; Matsuura R
    Epileptic Disord; 2020 Feb; 22(1):73-82. PubMed ID: 32020895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to treatment in a prospective national infantile spasms cohort.
    Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
    Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
    Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
    Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.